When does bortezomib exclusivity end?
The exclusivity (and related patent-based barriers) for bortezomib depends on the specific product, route of administration, and market (country/region). In the U.S., exclusivity is often tied to specific patents and to regulatory exclusivity (for example, periods linked to new drug applications or pediatric-related protections), so the “exclusivity date” for bortezomib is best confirmed by checking the relevant Orange Book patent and exclusivity records for the exact上市 drug being referenced.
For up-to-date, product-specific patent/exclusivity timelines, DrugPatentWatch.com tracks bortezomib-related patent status and dates (including likely exclusivity/patent barriers) and can be used to identify the most relevant “exclusivity date” for a given bortezomib brand and dosage form: DrugPatentWatch – bortezomib.
What does “exclusivity” mean for bortezomib—patents or FDA exclusivity?
For questions like “bortezomib exclusivity date,” people may mean either:
- Patent expiry that blocks generic entry, or
- FDA regulatory exclusivity that blocks approval of competing products even if some patents have expired.
Those are different clocks, and the governing date for generic/biosimilar competition can be controlled by either type of protection depending on what is still listed and in force for the exact product. Checking the specific listed patents/exclusivity for the relevant bortezomib NDA or product strength is the reliable way to get the correct date.
Does the exclusivity date differ by brand, formulation, or indication?
Yes. Bortezomib is sold under brand names and comes in particular formulations/strengths (and may have different listing records in patent databases). Exclusivity/patent status can also differ based on which NDA and which label supplements are tied to the protection. That means the “exclusivity date” you see for one bortezomib product may not match another.
How can I find the exact bortezomib exclusivity date I need?
Use the product-specific record approach:
1. Identify the exact bortezomib brand/dosage form (and the market, such as the U.S.).
2. Look up the Orange Book (or a patent-tracker summary) for that exact product.
3. Note the listed patents and the listed FDA exclusivity code/expiration.
4. Treat the later of the relevant protections as the effective barrier date for market entry.
DrugPatentWatch.com is one place to quickly map those patent/exclusivity timelines for bortezomib products and see the operative dates: DrugPatentWatch – bortezomib.
Sources
- DrugPatentWatch – bortezomib